Fundraising Fox

Pamela Klein

Investor

Founder and Principal, PMK BioResearch at Ysios Capital

San Francisco, California, United States

About

Dr. Pamela M. Klein is founder and principal of PMK BioResearch, providing advisory and strategic consulting to the biotechnology industry, and serves as consulting Chief Medical Officer of Olema Oncology. She previously held Chief Medical Officer roles at several biotech companies, including Intellikine (acquired by Takeda), and worked at Genentech from 2001 to 2008, ending as Vice President of Development where she oversaw development of drugs such as trastuzumab, rituximab, pertuzumab and erlotinib. She earlier co-founded and served as research director for the National Cancer Institute–Navy Breast Care Center, holds a biology degree from California State University Northridge and a medical degree from Loyola University Chicago's Stritch School of Medicine, and trained in internal medicine and medical oncology.

Invests in

Biotech

Experience

  1. argenxIndependent Director; Board Of Directorscurrent2016 — presentThe Netherlands
  2. Frontier MedicinesIndependent Director; Board of Directorscurrent2023 — presentSouth San Francisco, California, United States
  3. ONA TherapeuticsIndependent Director, Board of Directorscurrent2023 — presentBarcelona, Catalonia, Spain
  4. Ysios CapitalVenture Partnercurrent2023 — presentBarcelona, Catalonia, Spain
  5. ShasqiBoard Director, Independentcurrent2023 — present
  6. PMK BioResearchOncologist - Independent Biotech/Pharma Consultant/Drug Development Strategycurrent2008 — present
  7. Patrys LimitedIndependent Director; Board Of Directors2019 — 2025Australia
  8. I-Mab BiopharmaInterim Chairperson, Board of Directors2024
  9. I-Mab BiopharmaIndependent Director; Board of Directors2020 — 2024United States; China
  10. F-star Therapeutics, Inc.Member, Board of Directors2020 — 2023United Kingdom
  11. Sardona TherapeuticsIndependent Director; Board of Directors2023San Francisco Bay Area
  12. Olema OncologyChief Medical Officer2019 — 2022San Francisco
  13. Spring Bank Pharmaceuticals, Inc.Member, Board of Directors2019 — 2020Massachusetts, United States
  14. Intellikine IncChief Medical Officer2008 — 2011
  15. GenentechVice President, Clinical Development, Oncology2001 — 2007
  16. National Cancer InstituteResearch Director, NCI-Navy Breast Center1995 — 2001

Education

  1. Loyola University Chicago Stritch School of MedicineM.D., Oncology1988 — 1992
  2. California State University, NorthridgeBachelor's degree, Biology

Skills & more

Biotechnology64Drug Development56Oncology81DiagnosticsClinical Research32Drug Discovery15Clinical Trials20Clinical Development50Cancer17FDA2Medicine5Hardware Diagnostics3
+12 moreBiomarkersLifesciencesMolecular BiologyPharmaceutical IndustryImmunologyInfectious DiseasesTranslational ResearchHematologyMedical AffairsINDPharmacologyAssay Development

From Pamela's professional profile.

Same school

Shared employers

Investments

Board seats

ArgenxF-Star TherapeuticsI-Mab BiopharmaJiya Acquisition CorporationPatrys

Per the firm's website.

Colleagues at Ysios Capital